But the current study demonstrated that this is achieved by promoting a pro-tumor microenvironment, with increased CAF and macrophage infiltration, and by modulating the CCL5-CCR5 and CXCL12-CXCR4 chemokine axes at the primary tumor. The gene discussed is CCR5; the disease is neoplasm.